APBCS DAY 1 | 5th March 2022

15:30 - 15:35

Opening Remarks
Rebecca Dent , Singapore | Shaheenah Dawood , United Arab Emirates | Lee Soo Chin , Singapore

15:35 - 16:05

Advances of Immunotherapy from Early to Metastatic TNBC. Topic Supported by: MSD
Rebecca Dent , Singapore | Javier Cortes , Spain

16:05 - 16:35

Satellite Symposium– DKSH | “Same, Same But Different: Not all CDK 4/6 Inhibitors are the Same.”
Yap Yoon Sim , Singapore | Nadia Harbeck , Germany

16:35 - 17:55

SESSION 1: Endocrine Therapy Early ER Positive
Benita Tan , Singapore | Elaine Lim , Singapore

16:35 - 16:55

SESSION 1: Endocrine Therapy Early ER Positive | Year in Review for Early-Stage ER positive
Stephen Johnston , United Kingdom

16:55 - 17:25

SESSION 1: Endocrine Therapy Early ER Positive | Challenge Your Expert
Elaine Lim , Singapore | Janice Tsang , Hong Kong | Nadia Harbeck , Germany | Kiley Loh , Singapore | Yen-Shen Lu , Taiwan | Mikael Hartman , Singapore | Ava Kwong , Hong Kong

17:25 - 17:55

SESSION 1: Endocrine Therapy Early ER Positive | Tumor Board Discussion
Stephen Johnston , United Kingdom | Janice Tsang , Hong Kong | Nadia Harbeck , Germany | Kiley Loh , Singapore | Yen-Shen Lu , Taiwan | Mikael Hartman , Singapore | Ava Kwong , Hong Kong

17:55 - 18:00

Satellite Symposium – AstraZeneca | Welcome & Introduction
Tira Tan , Singapore

18:00 - 18:20

Satellite Symposium – AstraZeneca | Transforming Outcomes of Her2+ Metastatic Breast Cancer
Shanu Modi , USA

18:20 - 18:25

Satellite Symposium – AstraZeneca | Question and Answer

18:25 - 19:45

SESSION 2: Early HER2 positive
Shaheenah Dawood , United Arab Emirates | Khoo Kei Siong , Singapore

18:25 - 18:45

SESSION 2: Early HER2 positive | Best Approaches in 2022
Sara Tolaney , USA

18:45 - 19:15

SESSION 2: Early HER2 positive | Challenge Your Expert
Samuel Ow , Singapore | Winnie Yeo , Hong Kong | Virote Sriuranpong , Thailand | Sara Tolaney , USA | Shighera Saji , Japan | Chiun-Sheng Huang , Taiwan | Shanu Modi , USA | Azrif Muhammad , Malaysia

19:15 - 19:45

SESSION 2: Early HER2 positive | Tumor Board Discussion
Nitesh Rohatgi , India | Winnie Yeo , Hong Kong | Virote Sriuranpong , Thailand | Shighera Saji , Japan | Chiun-Sheng Huang , Taiwan | Shanu Modi , USA | Azrif Muhammad , Malaysia

19:45 - 19:48

Satellite Symposium - Pfizer | Introduction
Lee Soo Chin , Singapore

19:48 - 20:08

Satellite Symposium - Pfizer | Clinical & real-world perspectives in management of ER+ HER2- metastatic breast cancer
Massimo Cristofanilli , USA

20:08 - 20:13

Satellite Symposium - Pfizer | Question and Answers

20:13 - 20:15

Satellite Symposium - Pfizer | Closing Remark
Lee Soo Chin , Singapore

20:15 - 21:35

SESSION 3: Early Triple Negative
Jack Chan , Singapore | Faye Lim , Singapore

20:15 - 20:35

SESSION 3: Early Triple Negative | Pivotal Shifts in Early Stage TNBC
Harold Burstein , USA

20:35 - 21:05

SESSION 3: Early Triple Negative | Challenge Your Expert
Javier Cortes , Spain | Harold Burstein , USA | Sung-bae Kim , Korea South | Tira Tan , Singapore | Mastura Yusof , Malaysia | Rina Hui , Australia

21:05 - 21:35

SESSION 3: Early Triple Negative | Tumor Board Discussion
Jack Chan , Singapore | Harold Burstein , USA | Sung-bae Kim , Korea South | Tira Tan , Singapore | Mastura Yusof , Malaysia | Rina Hui , Australia